Lung Disease News |
FDA Committee Recommends Approval Of Nucala For Adult Asthma Patients
Lung Disease News An FDA advisory committee recently voted unanimously to approve Nucala for the treatment of severe asthma with eosinophilic inflammation in patients 18 and older. The committee, however, decided against the use of the therapy in adolescents aged … GSK's new asthma biologic gains FDA panel backing |
View full post on asthma – Google News